Background -In order to clarify the treatment of sleep hypoxaemias in Duchenne muscular dystrophy polysomnographic studies were performed on patients at home with the purpose of recruiting them into two clinical therapeutic trials. Observations concerning the nature of sleep hypoxaemia in these patients are presented. Methods -Twenty one non-ambulant patients with Duchenne muscular dystrophy aged 13-23 years with no symptoms of sleep hypoventilation or apnoea were studied for two consecutive nights with eight channel polysomnography. A comparative study was performed in 12 age matched normal male subjects. The evolution of sleep hypoxaemia with age was studied in 14 patients with Duchenne muscular dystrophy. Results -Thirteen of the 21 patients had hypoxaemia below 90% during sleep, and 12 of the 13 had discrete hypoxaemic dips in association with apnoeas; 60% of all apnoeas were obstructive in nature. The hypoxaemic periods became more frequent with increasing age and, in two patients at three year follow up, were more frequently associated with central or possibly "pseudocentral" apnoeas. Although the normal subjects had a few apnoeic episodes, none had sleep hypoxaemia below 90% saturation.
Several studies have indicated the presence of asymptomatic hypoxaemia during sleep in non-ambulant patients with Duchenne muscular dystrophy.1-5 It remains uncertain whether this hypoxaemia eventually causes symptoms or an early mortality since these patients may also have significant and independent cardiac disease. 6 The question of treatment of the hypoxaemia has not been fully addressed as little is known of its pathophysiology or natural history.
In an attempt to answer these questions we studied a cohort of patients with Duchenne muscular dystrophy to ascertain those who had sleep hypoxaemia. This was preliminary to entering these patients into two controlled trials of treatment: a short term double blind trial of slow release theophylline, and a long term randomised trial of prophylactic intermittent positive pressure ventilation by nasal mask. In this paper we describe our initial polysomnographic observations on the pathophysiology of sleep hypoxaemia in this disorder, a parallel study of healthy adolescent male controls, and follow up studies showing the evolution of hypoxaemia in the patients with Duchenne muscular dystrophy with increasing age.
Methods

PATIENTS
Twenty one non-ambulant patients with Duchenne muscular dystrophy attending the Muscle Clinic at the Hammersmith Hospital were studied. All had typical disease confirmed by grossly elevated serum creatine phosphokinase activity, abnormal muscle biopsy, and loss of ambulation by their 13th birthday. All patients had their diagnostic muscle biopsies performed before dystrophin analysis became available, but 12 had undergone gene deletions.7 Their mean age was 15 years (range [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Ten patients had undergone spinal stabilising surgery (Luque8) for scoliosis, and three others were awaiting operation. In an attempt to identify those who may be symptomatic, all patients completed a questionnaire designed to elicit symptoms of sleep hypoventilation or apnoea including difficulty in getting to sleep, number of awakenings, snoring, nightmares, early morning headaches, daytime sleepiness, and recurrent chest infections. This questionnaire was analysed blind by one of the authors (JZH). No patient had respiratory infection at the time of the study.
Vital capacity was measured with a portable spirometer (Micromedical, Rochester, Kent, UK) in the sitting and supine positions and expressed as a percentage of the expected normal value.9 Body mass index was calculated as weight/arm span2 (kg/M2).'0 Sleep studies were performed with an eightchannel Oxford Medilog multiparameter recorder which is the size of a small attache case. The eight channels comprised four standard sleep montage with Ag/AgCl electrodes and four respiratory channels as follows: EEG channel C4-A1, right supraorbital and left infraorbital electro-oculogram channels and submental electromyogram, thoracoabdominal movements by inductance plethysmography (Respibands; Ambulatory Monitoring Inc, Ardsley, New York, USA), air flow by oronasal thermistor, and arterial oxygen saturation by finger oximetry (Ohmeda Biox 3700).
Each subject was studied for two consecutive nights at home, maintaining normal lights out and lights on times. Initially one of the authors (YK) stayed overnight with the patients to supervise the study and detach the electrodes; later this proved unnecessary. Patients slept in their preferred position and were turned and repositioned as normal during the night. On the morning following the study patients were routinely asked about quality of sleep, number of awakenings, and the reasons for them.
The replay (Medilog 9000- 1 1 1 ponding reduction or absence of respiratory excursions, often with a gradual onset and recovery. Mixed apnoeas were a combination of the two. Only apnoeas of 10 seconds or more were analysed.
Repeat sleep studies were performed on 14 of the 21 patients. Seven were followed for > 18 months, the longest period being three years in two patients.
The studies were approved by the hospital ethical committee and informed written consent was obtained from the patients, their parents, and the normal male subjects (see below). Correlations were studied using the standard correlation coefficient with the Minitab computer program (Minitab Inc, Philadelphia, USA). CONTROL 
SUBJECTS
Twelve healthy adolescent males were also studied by identical methods. They had no respiratory illness and were not receiving any medication. Their average age was 14 years (range [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] .
Results
PATIENTS
The average weight of the patients was 50 2 kg, and the estimated mean body mass index was 16 (range 7-30) kg/mi (the average normal body mass index for this age group being 20 kg/M2).'0 The mean seated vital capacity was 35% of the predicted value for age (range 16-52%) with a mean fall of 8% when supine.
Automatic sleep staging with data analysis from all eight channels was possible for both nights on 16 patients. Detailed analysis of sleep, hypoxaemias, and apnoeas was virtually identical on nights 1 and 2 and we give results for night 2 only. All (fig 3) . Two patients, both followed for three years, showed a progressive fall in the proportion of obstructive apnoeas, from 90% to 20% in one ( fig 2B) , and from 60% to 30% in the other. Four of the originally non-hypoxaemic patients had follow up studies and one had developed hypoxaemic dips (fig 3) . The patient who was continuously hypoxaemic died two months after his sleep study. CONTROL 
SUBJECTS
The prestudy questionnaire did not elicit any symptoms of sleep hypoventilation or apnoea. Automatic sleep staging was possible in all 12, and the two nights of study gave similar results. The sleep data were also similar to the patients with Duchenne muscular dystrophy, mean values being: actual sleep time 404 minutes (range 288-510), REM time 67 minutes (28-155), sleep efficiency 92% (82-98%), REM latency 69 minutes (40-150), and awake period after sleep onset 31 minutes . The average awake baseline Sao2 was 98% (97-100%), and the fall at onset of sleep was 0-3%; none desaturated to < 90%.
Analysis of respiration showed that 11 subjects had apnoeas during the night, the pre- Age (years) Figure 3 Relation between age and frequency of hypoxaemic dips during sleep in 20 patients with Duchenne muscular dystrophy. Nine of the 14 patients who were followed up showed that the frequency of hypoxaemic dips increased with age. (This figure excludes the 23 year old patient with continuous sleep hypoxaemia.) dominant type of apnoea being central although one had obstructive apnoeas. The mean apnoea index was 2*9/hour of sleep (range 0 9-43) and there was no clustering. The subject with obstructive apnoeas showed two hypoxaemic dips of 5% below the baseline of 96%.
Discussion
The original purpose of our study was to recruit patients for a clinical trial. When the study was designed the nature and significance of the disturbed breathing during sleep was uncertain. Redding et al,'7 studying five patients with Duchenne muscular dystrophy aged 13-17 years, reported intermittent hypoventilation but no apnoeas and no desaturation. Manni et aP reported infrequent central apnoeas with desaturation in six of 11 patients with Duchenne muscular dystrophy aged 10-21 years, and postulated that the hypoxaemia arose as a result of the restrictive lung defect rather than the severity of the apnoeas. Smith et all reported desaturation during REM sleep in nine out of 14 patients with Duchenne muscular dystrophy aged 15-22 years, and the sleep disordered breathing constituted mainly hypopnoeas with greater attenuation of rib cage than abdominal movements. Central apnoeas occurred in eight, chest wall paradox occurred in one but not in association with apnoeas, and continued electromyographic activity was seen throughout REM related, apparently central, apnoeas in two. This persistent electromyographic activity prompted the authors to suggest an obstructive aetiology.
A later study2 of six patients with Duchenne muscular dystrophy aged [16] [17] [18] [19] [20] [21] [22] Our study provides further evidence of an obstructive rather than a central aetiology, because all but one of our hypoxaemic patients had apnoeas in association with persistence of chest wall movement, and sometimes with abdominal and rib cage paradox which was often of high amplitude. We cannot easily explain why previous authors have not reported similar findings. One possibility is that, as we studied younger patients than Smith and coworkers, our patients might have been better able to generate respiratory excursions in the presence of upper airways obstruction. This is supported by the evolution with age of apnoeas from obstructive to apparently central in two of our patients followed up for the longest period (three years).
The only way of resolving this issue would be to measure transdiaphragmatic pressures during sleep. We wished to minimise instrumentation of our subjects in order to recruit sufficient numbers for clinical trials. We have subsequently tried to persuade our patients to swallow oesophageal balloons for respiratory function tests, but without success. Nevertheless, using non-invasive techniques, it is more likely that obstructive apnoeas would be mistaken for central, rather than the reverse."9
The hypoxaemic apnoeas observed in our patients are likely to be of pathological significance. Apnoeas are less common in normal subjects of the same age and sex. Our finding of both central and obstructive apnoeas in healthy adolescent males corroborates those of previous workers, but both clustering of the apnoeas and an accompanying fall in oxygen saturation below 90% are uncommon.2>22 Furthermore, sequential studies in our patients showed that the hypoxaemias become more frequent and severe with age, although none had continuous hypoxaemia on follow up. We are not certain that the continuous hypoxaemia we observed in our oldest patient represents an "end stage" of the discrete hypoxaemic dips of the others, or whether another factor was operating in him, in particular cardiac involvement.6 23 Our desire to perform controlled trials has arisen out of the increasing use of ventilation for Duchenne muscular dystrophy2425 and the claim by Rideau 
